Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Adderall Stories

2013-02-14 08:28:18

DUBLIN, Ireland, February 14, 2013 /PRNewswire/ -- Shire (LSE: SHP, NASDAQ: SHPG) announces results for the year to December 31, 2012. Financial Highlights Full Year 2012(1) Product sales $4,407 million +12% Product sales excluding ADDERALL XR...

2013-02-11 08:26:34

ATLANTA, Feb. 11, 2013 /PRNewswire/ -- IQ Enhance, the natural Adderall® and ADHD drug alternative for college and university students, is looking to move from online sales into retail stores. Designed as a natural nootropic cognitive supplement to increase focus and concentration, improve memory, enhance brain activity and boost energy, IQ Enhance is a natural alternative to pharmaceutical drugs that are being used and abused in campuses across North America. IQ Enhance's Cognitive...

2013-02-08 08:25:46

PHILADELPHIA, February 8, 2013 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG), announces that its subsidiary, Shire LLC, has settled all pending litigation with Impax Laboratories, Inc. ("Impax") over Shire's supply of an authorized generic version of Adderall XR. Shire has been supplying Impax with authorized generic Adderall XR since October 2009 pursuant to a supply agreement between the parties. In November 2010, Impax filed suit claiming that Shire was in breach...

2013-02-01 12:23:46

PHILADELPHIA, February 1, 2013 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG), today announced that it has reached an agreement in principle to resolve the previously disclosed civil investigation into Shire's U.S. sales and marketing practices relating to ADDERALL XR(R), VYVANSE(R) and DAYTRANA(R)[1]. The investigation was led by the U.S. Attorney's Office for the Eastern District of Pennsylvania, and Shire disclosed the investigation in 2009. The agreement also...

2013-01-29 08:30:46

DALLAS, Jan. 29, 2013 /PRNewswire/ -- AffordRx, a prescription drug card, is offering an Adderall coupon to help families afford the medications they need. Adderall is an amphetamine-related drug that is commonly prescribed for children and adults with Attention Deficit Hyperactivity Disorder (also referred to as ADHD) or narcolepsy. Because of the controversy associated with both ADHD diagnoses and with the drugs themselves, it can be confusing for parents to know how to best...

ADHD Medication Lowers Crime
2012-11-23 05:10:50

Connie K. Ho for redOrbit.com — Your Universe Online A study by British and Swedish researchers recently found that medication for attention deficit-hyperactivity disorder (ADHD) could help reduce some instances of criminal behavior. Medications like Adderall, Ritalin, and other drugs could help limit hyperactivity and elevate the ability to focus. Reuters reports that Ritalin is produced by Novartis, a Swedish drug maker, while companies sell other ADHD drugs like Eli Lilly...

2012-11-13 16:25:33

CHADDS FORD, Pa., Nov. 13, 2012 /PRNewswire/ -- Endo Health Solutions Inc. (Nasdaq: ENDP) announced today that its subsidiary, Endo Pharmaceuticals Inc., has supplemented its OPANA(®) ER Citizen Petition to include emerging safety data that demonstrate that the introduction in the first quarter of 2012 of the reformulated OPANA ER (oxymorphone HCl) designed to be crush-resistant, is reducing rates of abuse. Comparisons of abuse rates for OPANA ER, from the third quarter of 2011 through...

2012-09-26 10:24:30

CHADDS FORD, Pa., Sept. 26, 2012 /PRNewswire/ -- Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions (Nasdaq: ENDP), announced today that the company has received Paragraph IV Certification Notices from Teva Pharmaceuticals and Amneal Pharmaceuticals each advising of the filing of Abbreviated New Drug Applications (ANDAs) for generic versions of OPANA(®) ER (Oxymorphone HCl). Endo intends to vigorously defend OPANA ER's intellectual property rights and will pursue all...

2012-09-13 22:23:02

SHAWNEE, Kan. and JERUSALEM, Sept. 14, 2012 /PRNewswire/ -- Bayer HealthCare LLC and Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that they have signed an agreement in which Bayer will acquire the U.S. based animal health business of Teva for up to 145 million USD. The purchase price includes an upfront payment of 60 million USD plus a total of 85 million USD in milestone payments, which are linked to the successful and timely achievement of manufacturing and sales...

2012-09-06 02:32:21

CHADDS FORD, Pa., Sept. 6, 2012 /PRNewswire/ -- Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. (Nasdaq: ENDP), today announced that, according to the latest IMS data estimates, the reformulated OPANA(®) ER (oxymorphone HCl) incorporating Grunenthal's INTAC(®) Technology designed to be crush-resistant accounts for more than 90 percent of the OPANA ER total prescription volume. "Patient safety, including appropriate use of our products, remains one of Endo's...